Clinical Trials Directory

Trials / Completed

CompletedNCT02124330

Protein Sorbent Properties of Montmorillonite in Vitro and in Vivo Models

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Luca Ronfani · Academic / Other
Sex
All
Age
25 Years – 30 Years
Healthy volunteers
Accepted

Summary

Montmorillonite (MONT) is a phyllosilicate layered mineral with unique physicochemical properties, such as swelling and cation exchange capability. The aim of this project is to study, in healthy volunteers, the in vivo ability of MONT to reduce protein intestinal uptake. Furthermore, the study analyzed in vitro the MONT ability of immobilizing proteins.

Detailed description

Montmorillonite (MONT) is a phyllosilicate layered mineral; chemically it is hydrated sodium calcium aluminium magnesium silicate hydroxide. Potassium, iron, and other cations are common substitutes and the exact ratio of cations varies with source. Due to its unique physicochemical properties, such as swelling and cation exchange capability, as well its mechanical and thermal stability, MONT can be efficiently used as matrix for immobilization of proteins with high molecular weight (e.g. Albumin) and proteins with low molecular weight (e.g.Aflatoxines). Therefore, MONT is used for therapeutic purposes, in pharmaceutical formulations and in food preparations. In vitro assays made in our laboratory, showed that MONT absorbs, in stable manner, alimentary proteins: beta-lactoglobulins, alfa lactoalbumines and the ratio MONT-protein (w/w) 1:3, 1:5, 1:15, results in the protein capture of 50, 27, 0 % of proteins respectively. The aim of this project is to study, in healthy volunteers, the in vivo ability of MONT to reduce protein intestinal uptake evaluated with the blood MONT- protein ratio. Furthermore, the study analyzed in vitro the MONT ability of immobilizing proteins at different ratio (w/w) 1:3, 1:5, 1:15.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTmontmorillonite 5 g5g montmorillonite + 15 g protein (ratio 1:3)
DIETARY_SUPPLEMENTmontmorillonite 3 g3g MONT+ 15 g protein (ratio 1:5)
DIETARY_SUPPLEMENTMontmorillonite 1 g1g MONT+ 15 g protein (ratio 1:15)

Timeline

Start date
2013-06-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2014-04-28
Last updated
2017-03-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02124330. Inclusion in this directory is not an endorsement.